三诺生物：关于预计触发可转债转股价格向下修正条件的提示性公告

Core Viewpoint - Sanofi Bio's stock price has been below 80% of the conversion price for 10 trading days, which may trigger a downward adjustment of the conversion price for its convertible bonds [1] Group 1 - Sanofi Bio announced that from December 22, 2025, to January 6, 2026, its stock price has closed below the conversion price of 27.57 yuan per share for 10 trading days [1] - The company expects to trigger the conditions for a downward adjustment of the conversion price as stipulated in the prospectus for its convertible bonds [1] - If the conditions for the downward adjustment are met, the company will follow relevant laws and regulations to fulfill its review procedures and information disclosure obligations [1]